Pharmaffiliates Powers Golpura Village with Solar Energy, Advancing Sustainable Rural Development

Pharmaffiliates Pvt. Ltd., a global name in pharmaceutical reference standards and analytical solutions, has extended its commitment to community welfare by providing complete solar lighting infrastructure to Golpura village in Panchkula district, Haryana. The project, part of the company's Corporate Social Responsibility (CSR) initiatives, reflects its dedication to sustainable development and renewable energy adoption.

The installation of modern solar streetlights across the village was officially launched on June 9, delivering improved visibility, enhanced safety at night, and an uplifted quality of life for residents.

In a parallel effort to strengthen local education, Pharmaffiliates equipped the government school in Golpura with a digital smart board and provided a reliable uninterrupted power supply system, ensuring seamless teaching even during power cuts.

With an investment of around ₹3.5 lakhs, the initiative covered the supply, installation, and commissioning of the solar infrastructure in key village areas. The launch ceremony witnessed enthusiastic participation from community members, village leaders, and educational authorities.

Commenting on the project, Ashok Kumar, CSR Manager at Pharmaffiliates, said:

"Our goal is to use our capabilities to bring meaningful change to communities. The Golpura solar initiative is a clear example of how clean, renewable energy can positively transform lives at the grassroots level."

Pharmaffiliates remains committed to implementing CSR projects that combine environmental sustainability with social empowerment, in line with national goals for renewable energy in rural India.

Media Contact:
CSR & Communications Department
Pharmaffiliates Pvt. Ltd.
Email: bda@pharmaffiliates.com
Phone: +91-9216959588

Plot Number 225, Industrial Area, Phase II, Panchkula, Haryana- 134113, India

About Pharmaffiliates
Established in 2001, Pharmaffiliates is a GLP-compliant, ISO 17034-accredited, and USFDA-audited company specializing in reference standards, impurity profiling, analytical testing, custom synthesis, and CDMO solutions. Serving clients in more than 65 countries, the company is recognized for its dedication to quality, innovation, and social responsibility.

This release was published on openPR.